Scientia Ventures

About

Portfolio

People

Podcasts

News

Portfolio

People

Podcasts

News

About

Portfolio

About

People

Podcasts

News

Portfolio

People

Podcasts

News

About

Scientia Ventures

knowledge is power

In short

Intelligent Investment in Healthcare

In Numbers

31 Companies Funded

5 IPOs

31

5

Latest Press

Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape

Read

Royalty Pharma And Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement For Niktimvo

Read

FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors

Read

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Read

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

Read

Highlights

Royalty Pharma

Transforming the funding of life sciences through collaborative capital, Royalty Pharma developed and is the leader in the pharmaceutical royalty business.

Royalty Pharma

RP

ADC Therapeutics

ADC Therapeutics is focused on the development of proprietary Antibody Drug Conjugates for the treatment of both solid and hematological cancers.

ADC Therapeutics

ADCT

Intra-Cellular Therapies

Intra-Cellular Therapies is a leading biopharmaceutical company founded by Nobel Prize winner: Paul Greengard...

Intra-Cellular Therapies

ICT

Intelligent Investment
in Healthcare

Scientia Ventures
Copyright 2020

Thank you!
Oops! Something went wrong while submitting the form.

SIGn
UP

Scientia Ventures™

DisclosuresPrivacy Policy and Terms of Use
Copyright 2023